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Unexpected malignancy diagnosed in presumed symptomatic 
and asymptomatic endometrial polyps and submucosal myomas 
after hysteroscopic resection
Utajony nowotwór złośliwy rozpoznany w objawowych i bezobjawowych zmianach 
podejrzanych o polipa endometrialnego i mięśniaka podśluzówkowego  
po resekcji histeroskopowej
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Hysteroscopy is the treatment of choice of benign intrauterine conditions, whenever feasible. During hysteroscopic 
procedures performed with the intent of resecting myomas and polyps, there is a potential risk of an unexpected diagnosis 
of an occult malignant lesion. Objective: To estimate the incidence of occult uterine malignancy in women undergoing 
hysteroscopic electroresection due to a diagnosis of benign uterine lesions: endometrial polyps and submucosal myomas, 
by ultrasound. Material and methods: The electronic database of patients hospitalized between January 2010 and December 
2016 in the Department of Gynecology and Oncology of the Jagiellonian University was searched for women who had 
undergone hysteroscopic surgery due to presumed endometrial polyps and submucosal myomas. Medical records of 
1,006 eligible women were analyzed. Results: Ten cases (10/1,006; 1%) of occult endometrial cancer, 2 cases (2/1,006; 0,2%) 
of low-grade endometrial stromal sarcoma and 3 cases (3/1,006; 0,3%) of atypical endometrial hyperplasia were found 
postoperatively. One case of ovarian cancer coexisting with endometrial cancer was diagnosed. Of the factors analyzed, only 
age, menopausal status and abnormal uterine bleeding turned out to be significant endometrial cancer risk factors. Too few 
sarcoma cases did not allow similar estimates. We did not observe worsening of the prognosis, and all 15 patients who 
underwent hysteroscopic resection of the unforeseen malignancy or precancerous lesion are still alive within 2–8 years of 
follow-up. Conclusions: The incidence of unlooked-for malignancy in patients with benign intracavitary lesions, 
i.e. endometrial polyps and submucosal myomas, is relatively high. No negative effects of hysteroscopic resection on potential 
further treatment and prognosis have been proven so far. High risk of malignancy in women with presumed benign 
intracavitary lesions may indicate that not all these women are appropriate candidates for laparoscopic procedures with power 
morcellation, particularly when no previous histopathological verification is ordered.
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Histeroskopia jest leczeniem z wyboru łagodnych zmian wewnątrzmacicznych. Podczas zabiegów histeroskopowych 
wykonywanych z zamiarem wycięcia mięśniaków podśluzówkowych i polipów endometrialnych istnieje potencjalne ryzyko 
nieoczekiwanego rozpoznania utajonego nowotworu złośliwego. Cel: Ocena częstości występowania utajonego nowotworu 
złośliwego trzonu macicy u kobiet poddawanych histeroskopowej elektroresekcji z powodu ultrasonograficznej diagnozy 
łagodnych zmian: polipa endometrialnego i/lub mięśniaka podśluzówkowego. Materiał i  metody: Wykorzystując 
elektroniczną bazę danych archiwalnych Kliniki Ginekologii i Onkologii Uniwersytetu Jagiellońskiego, wyszukano pacjentki 
poddane histeroskopii operacyjnej w przedziale czasowym od stycznia 2010 do grudnia 2016 roku. Przeanalizowano 
dokumentację medyczną 1006 kwalifikujących się kobiet. Wyniki: W preparatach tkankowych z histeroskopii stwierdzono 
10 przypadków (10/1006; 1%) ukrytego raka endometrium, 2 przypadki (2/1006; 0,2%) mięsaka i 3 przypadki (3/1006; 0,3%) 
atypowego rozrostu endometrium. Odnotowano jeden przypadek raka jajnika współistniejącego z rakiem endometrium. 
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However, despite these potential threats, hysteroscopy is con-
sidered the most accurate method of diagnosing EC(5,6). It is 
believed that the risk of neoplastic cell passage when using 
lower medium pressure (25–45 mm Hg) is small(7). Never-
theless, during operative hysteroscopy performed for benign 
lesions, higher pressures (70–110 mm Hg) are usually needed, 
which increases the risk of tumor cell release to the peritoneal 
cavity. Research on the impact of tumor cell spread into the 
peritoneal cavity on patient survival in women subjected to 
accidental hysteroscopic resection of an unexpected uterine 
malignancy involves a few series of cases(8). Studies estimat-
ing the incidence of unforeseen malignancy during opera-
tive hysteroscopy with the intention of treating benign lesions 
are scarce(9). However, both symptomatic and asymptomatic 
patients as well as clinicians wish to know the risk of malig-
nant neoplasm when ultrasonographic suspicion of benign 
tumor is made. The primary aim of this study was to estimate 
the incidence of occult uterine malignancy in women under-
going hysteroscopic electroresection due to ultrasonographic 
diagnosis of benign uterine lesions: endometrial polyps and 
submucosal myomas. The secondary aims were (i) to esti-
mate and compare the incidence of unexpected malignancy 
in symptomatic and asymptomatic women as well as those 
with and without AUB and PMB, and (ii) to assess poten-
tial factors for malignant lesions. Finally, we showed available 
data from the follow-up of patients with accidentally resected 
malignant tumors.
MATERIAL AND METHODS
Study design
This retrospective cohort study was based on archival data 
of the Department of Gynecology and Oncology of the 
Jagiellonian University in Krakow, Poland. The consent 
was obtained from the local bioethics committee to carry 
out the study. Medical data were extracted from electronic 
databases as well as traditional documentation, using codes 
from the International Statistical Classification of Diseases 
and Related Health Problems (ICD-10) and the Interna-
tional Classification of Medical Procedures (ICD-9), tar-
geted for endometrial polyp (N84.0), submucosal myoma 
INTRODUCTION
Hysteroscopy is the treatment of choice of symptom-atic benign intrauterine lesions, such as submuco-sal myomas and uterine polyps. During hystero-
scopic procedures performed with the intent of resection of 
myomas or polyps, there is a potential risk of an acciden-
tal diagnosis of an occult malign tumor, i.a. sarcoma and 
endometrial cancer (EC). The risk of malignancy in endo-
metrial polyps reported by the American Association of 
Gynecologic Laparoscopists (AAGL) is estimated to vary 
between 0% and 12.9%(1). Most often, uterine cavity pathol-
ogies are recognized based on the accompanying symptoms, 
i.e. abnormal uterine bleeding (AUB): AUB-Polyp (AUB-P) 
in association with endometrial polyp and AUB-Leiomyoma 
(AUB-L) in association with submucosal myoma, according 
to the International Federation of Gynecology and Obstet-
rics (FIGO) nomenclature: the PALM-COEIN classification 
in women of reproductive age(2), or in women with post-
menopausal bleeding (PMB)(1). It should be noted that, in 
asymptomatic women who undergo a gynecological exam-
ination with transvaginal ultrasound, endometrial pol-
yps and submucosal myomas are commonly diagnosed. 
Patients with these benign lesions, not only symptomatic, 
but also asymptomatic, are commonly treated by means of 
hysteroscopy. However, surgery of asymptomatic benign 
lesions is a subject of debate without support by robust evi-
dence. One of the arguments is the possibility of a histolog-
ical examination of removed tissue allowing the exclusion 
of premalignant conditions and malignancy. The literature 
shows that some factors, such as AUB, postmenopausal sta-
tus, PMB, age >60 years, diabetes mellitus, arterial hyperten-
sion, obesity, and hormonal therapy, may be associated with 
higher risk of premalignant and malignant lesions(3).
Although, hysteroscopy is considered a gold standard pro-
cedure for removal of benign intrauterine lesions, there is 
a potential risk of spreading neoplastic cells when resect-
ing an unexpected malignant tumor. During hysteroscopic 
procedures, the uterine cavity is dilated with the medium 
under pressure(4). In this case, uterine occult malignant tis-
sue is a potential risk of tumor cell passage into the abdom-
inal cavity as well as their flight to damaged blood vessels. 
Spośród analizowanych zmiennych jedynie wiek, status menopauzalny i nieprawidłowe krwawienie maciczne okazały się 
znaczącymi czynnikami ryzyka raka endometrium. Znikoma liczba przypadków utajonego mięsaka nie pozwoliła na 
podobne oszacowania. Nie zaobserwowano pogorszenia rokowania, a wszystkie 15 kobiet poddanych histeroskopowej 
resekcji niewykrytego nowotworu złośliwego lub stanu przednowotworowego pozostaje przy życiu w ciągu 2–8 lat obserwacji. 
Wnioski: Częstość występowania utajonych nowotworów złośliwych u pacjentek z łagodnymi zmianami wewnątrzjamowymi, 
tj. polipami endometrialnymi i mięśniakami podśluzówkowymi, jest stosunkowo wysoka. Dotychczas nie udowodniono 
negatywnego wpływu resekcji histeroskopowej na ewentualne dalsze leczenie i rokowanie. Wysokie ryzyko nowotworów 
złośliwych u kobiet z prawdopodobnie łagodnymi zmianami wewnątrzjamowymi może wskazywać na to, że nie wszystkie 
te kobiety są odpowiednimi kandydatkami do zabiegów laparoskopowych z użyciem morcelacji elektromechanicznej, 
zwłaszcza gdy rezygnuje się z przedoperacyjnej weryfikacji histopatologicznej endometrium.
Słowa kluczowe: histeroskopia, utajony nowotwór złośliwy, rak endometrium
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were performed by highly experienced hysteroscopists. 
Transrectal ultrasound was used in selected cases of fibroids 
with deep penetration of the myometrium (G2 according to 
PALM-COEIN/ESH)(10). The operating theatre was equipped 
with KARL STORZ endoscopic instruments throughout the 
observation period. During surgical procedures, different 
tools were used, mainly monopoloar and bipolar resecto-
scopes (26 Fr) and 4 mm oblique view (30°) optics. Polyps 
and myomas were removed with the use of loop electrodes. 
In cases where no suspicious lesions in the uterine cavity 
were found in hysteroscopy, an endometrial biopsy was per-
formed. During surgery, efforts were made not to exceed the 
pressure of 120 mm Hg in the uterine cavity. Saline or Pur-
isole (Fresenius, Bad Homburg, Germany) were used as the 
dilating medium. The collected tissue material was fixed in 
10% formalin and sent for pathological verification.
Histological examination
Tissue specimens were evaluated in the Department 
of Pathomorphology of the Jagiellonian University in 
Krakow. In debatable cases, specimens were referred to an 
expert pathologist to assure the highest quality of histo-
logical evaluation.
Statistical analysis
The qualitative variables were described using frequencies 
(n) and percentages (%). The quantitative variables were 
described with means and standard deviations (SDs) when 
they were normally distributed, and using quartiles oth-
erwise. Congruence with normal distribution was tested 
using Kolmogorov–Smirnov test. Correlations between 
analyzed variables were estimated using Cramer’s V coef-
ficient for qualitative variables. Differences between means 
of normally distributed variables between two groups were 
assessed using Student’s t-test for independent samples, 
whereas differences in distributions of non-normally dis-
tributed ones were tested using Mann–Whitney test.
RESULTS
Patients’ characteristics
Using the above-mentioned search criteria as well as inclu-
sion and exclusion criteria, records of 1,006 women were 
obtained and then analyzed. Six hundred and fifty-four 
women (654/1,006; 65%) were younger than 45 years of age 
(65%), and 352 were 45 years old and older (35%). Eight 
hundred and eighteen women (818/1,006; 81,3%) were 
at premenopausal age and 188 (18,7%) were postmeno-
pausal. Women who gave birth at least once accounted 
for 62.2% of the study population and nulliparous women 
constituted 37.8%. Characteristics of the study population, 
like median age, body mass index (BMI), gravidity, parity, 
hemoglobin level and surgery time, are shown in Tab. 1. 
(D25.0) and hysteroscopic resection of the lesion in 
the uterus (68.234). Patients’ demographic and clinical data, 
i.e. preoperative diagnosis, reported symptoms, indications 
to surgical treatment, postoperative diagnosis and histo-
pathological findings, were obtained.
The inclusion criterion was the selection for hysteroscopic 
electroresection of a  uterine lesion. Women undergo-
ing hysteroscopic endometrial ablation, electroresection 
or biopsy, hysteroscopic metroplasty, hysteroscopic resec-
tion of retained placental tissue, hysteroscopic resection 
of cesarean scar defect, hysteroscopic synechiotomy, and 
hysteroscopic IUD (intrauterine device) removal were not 
considered eligible for the study. Women suffering from 
previously diagnosed EC or atypical endometrial hyper-
plasia (AH) were also considered ineligible, while women 
with a diagnosis of indeterminate intracavitary lesions sus-
pected of endometrial polyps and submucosal myomas 
were included in the study.
In order to estimate the risk of an accidental diagnosis 
of occult uterine malignancies during operative hyster-
oscopy performed due to a submucosal leiomyoma and 
uterine polyp, all hysteroscopic procedures performed in 
2010–2016 were counted, taking into account the above-
mentioned criteria.
Presurgical assessment
All women were examined and then considered candidates 
for surgical treatment by a physician who was a specialist 
in obstetrics and gynecology or gynecological oncology. 
The gynecological examination was performed in a stan-
dardized way and consisted of a speculum and bimanual 
examination, transvaginal ultrasonography, and was fol-
lowed by detailed counseling. All patients had cervical 
cytology done within the last 12 months.
Symptomatic patients reporting heavy menstrual bleeding, 
intermenstrual bleeding, postmenopausal bleeding, recur-
rent miscarriages or infertility were deemed eligible for 
hysteroscopy. In some cases, after taking into account the 
results of gynecological and ultrasound exams and consid-
ering risk factors, asymptomatic patients were also selected. 
All patients agreed to the proposed surgical treatment.
Surgery
Hysteroscopic procedures were performed within the oper-
ating theatre of the Department of Gynecology and Oncol-
ogy under general anesthesia. Surgeons representing various 
levels of expertise in hysteroscopy performed the interven-
tions: from physicians during residency training in cases of 
polyps to experienced gynecologists in cases of submucosal 
myomas of grade 0 (G0) and 1 (G1) by the European Soci-
ety for Hysteroscopy (ESH)/PALM-COEIN classifications(2). 
The most difficult procedures of excising grade 2 (G2) sub-
mucosal myomas with deep penetration of the myometrium, 
as well as large G0 and G1 submucosal myomas (>3 cm), 
Iwona Gawron, Artur Ludwin
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None of the quantitative variables had a normal distribu-
tion (in the Kolmogorov–Smirnov test p < 0.01). Median 
age was 42 years (range 35–49 years) and median BMI was 
24 (range 21.26–26.85). Median gravidity was 1 (range 0–2) 
and median parity was also 1 (range 0–2). Women, who 
were pregnant 4 times and more accounted for 5.3% of the 
population. Median preoperative hemoglobin level was 
13 g/dL (range 12.1–13.8). Median duration of surgery, 
from the beginning to the end of general anesthesia, was 
45 minutes (range 40–60).
The primary indication for surgery was an endometrial 
polyp (84.6%) and a submucosal myoma (11.9%), rarely 
a fibroid coexisting with a polyp (0.7%). Pathology of the 
uterine cavity with an indeterminate ultrasound character 
was detected in 2.8% of women (Tab. 2).
The most frequently reported symptom was AUB, i.e. heavy 
menstrual bleeding (HMB; 36.2%), irregular menstrual 
bleeding (IMB; 11.2%), heavy and irregular menstrual 
bleeding (HMB/IMB; 8.5%) and PMB (4.5%). 39.6% of 
women did not report any abnormal uterine bleeding. 
In 7.1% of women, the indication for surgery was infertility. 
Pelvic pain was reported by 13.8% of women. In some 
women, the coexistence of two or more symptoms was 
observed, hence the sum in Tab. 3 exceeds 100%.
Adverse events  
and complications of surgery
Four complications were noted: perforation of the uter-
ine wall in 2 cases with subsequent laparoscopic suturing, 
single overload syndrome and one case of postoperative 
infection (adnexitis).
Benign intracavitary lesions: 
endometrial polyps and 
submucosal myomas
The study involved 1,006 women with presumed endome-
trial polyps, submucosal myomas, submucosal myomas 
coexisting with polyps, and those with inconclusive benign 
conditions suspected of a myoma or a polyp. In this pop-
ulation of women, 12 patients (12/1,006; 1.2%) were post-
operatively diagnosed with a malignancy: 10 with EC and 
2 with endometrial stromal sarcoma (ESS). Detailed patho-
logical findings are presented in Tab. 4.
Presumed endometrial polyps 
and malignancy
There were 851/1,006 (84.6%) patients with an initial diag-
nosis of an endometrial polyp, 7/1,006 (0.7%) with both an 
endometrial polyp and a submucosal myoma, and 28/1,006 
(2.8%) with an inconclusive ultrasonographic diagnosis as 
to a uterine polyp or submucosal myoma. Considering all 
these diagnoses as potential endometrial polyps, there were 
Preoperative diagnosis of uterine cavity N %
Myoma 120 11.9
Polyp 851 84.6
Polyp + myoma 7 0.7
Inconclusive diagnosis 28 2.8
N = 1,006 women.
Inconclusive diagnosis – polyp or polypous endometrium or myoma.
Tab. 2. Preoperative diagnosis of the uterine cavity
Reported symptoms N %
Symptomatic: 696 69.2
• AUB/PMB 608 60.4
• Infertility 71 7.1
• Pain 139 13.8
Asymptomatic 310 30.8
AUB + PMB 608 60.4
No AUB + PMB 398 39.6
AUB: 563 56.0
• AUB/HMB 364 36.2
• AUB/IMB 113 11.2
• AUB-HMB/IMB 86 8.5
PMB 45 4.5
N = 1,006 women.
AUB/PMB – abnormal uterine bleeding and postmenopausal bleed-
ing; AUB – abnormal uterine bleeding; PMB – postmenopausal bleeding; 
AUB/HMB – heavy menstrual bleeding; AUB/IMB – irregular menstrual 
bleeding; AUB-HMB/IMB – heavy and irregular menstrual bleeding.
Tab. 3. Reported symptoms
Mean −95% CI +95% CI SD Min Max Median Lower 
quartile
Upper 
quartile
Age 43 43 44 12 17 84 42 35 49
BMI 24.71 24.40 25.01 4.91 13.21 53.51 24.00 21.26 26.85
Gravidity 1 1.25 1.41 1.27 0.00 7.00 1.00 0.00 2.00
Parity 1 1.11 1.25 1.14 0.00 6.00 1.00 0.00 2.00
Hemoglobin (g/dL) 12.79 12.67 12.90 1.47 5.30 22.30 13.00 12.10 13.80
Surgery time (min.) 50.28 49.06 51.50 19.42 10.00 205.00 45.00 40.00 60.00
Tab. 1. Population characteristics
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886/1,006 (88.1%) women with presumed polyps. Within 
this group, malignant lesions were recognized in 11/886 
(1.2%) women: EC in 10/886 (1%) and ESS in 1/866 (0.1%). 
Among women with a conclusive ultrasonographic diagno-
sis of an endometrial polyp alone, ten out of 851 (10/851; 
1.2%) were diagnosed with malignancies, i.e. EC in 9/851 
(1.1%) and ESS in 1/851 (0.1%). In the group of women 
with AUB/PMB and a conclusive diagnosis of an endome-
trial polyp alone, there were 6/492 (1.2%) malignancies (5 EC 
and 1 ESS). Among patients suffering from AUB/PMB with 
a preoperative diagnosis of a polyp, a polyp coexisting with 
a submucosal myoma and an inconclusive diagnosis, 6 cases 
of malignancy (6/513; 1.7%) were postoperatively diagnosed.
Presumed submucosal myomas  
and malignancy
There were 120 (120/1,006; 11.9%) patients with an ini-
tial diagnosis of a submucosal myoma, 7/1,006 (0.7%) with 
both an endometrial polyp and a submucosal myoma, and 
28/1,006 (2.8%) with a diagnosis uncertain as to a polyp or 
submucosal myoma. Considering all the above diagnoses as 
potential submucosal myomas, there were 155 (155/1006; 
15.4%) women with presumed submucosal myomas. In this 
group, 2 (2/155; 1.3%) malignancies (1 ESS and 1 EC) were 
postoperatively recognized. Taking into account only women 
with submucosal myomas, there was one case of ESS (1/120; 
1.7%). Among patients suffering from AUB/PMB with a pre-
operative diagnosis of a submucosal myoma, both a polyp 
and a submucosal myoma, and an inconclusive diagnosis, 
2 (2/116; 1.7%) cases of malignancy (1 EC and 1 ESS) were 
postoperatively diagnosed.
Malignancy, symptoms and abnormal 
uterine bleeding/postmenopausal bleeding
Malignancy was present in 9/696 (1.3%) and 3/310 (1.0%) 
symptomatic (AUB/PMB, pelvic pain or infertility) and 
asymptomatic women, respectively. Relative risk of unex-
pected malignancy in symptomatic women in comparison 
to asymptomatic ones was 1.3 (95% confidence interval, CI: 
0.4 to 4.9, p = 0.7). Malignancy was present in 8/608 (1.3%) 
and 4/398 (1.0%) women with AUB/PMB and without 
AUB/PMB, respectively. There were 6 cases of EC and 2 cases 
of ESS among women with AUB/PMB and 4 cases of EC 
in women without AUB/PMB. Relative risk of occult malig-
nancy in women with AUB/PMB in comparison to those 
without AUB/PMB was 1.3 (95% CI: 0.4 to 4.3, p = 0.7).
Endometrial cancer
There was a significant difference in the mean age of women 
with EC compared to the population average (54.8 vs. 43.3; 
p = 0.005). There was a  significant correlation between 
EC and the type of uterine bleeding (p = 0.005; Cramer’s 
V = 0.14). Most often, cancer was diagnosed in women with 
PMB (6.7%), followed by women with HMB/IMB (1.2%), 
HMB (0.6%) and no AUB (0.5%). There was no EC in the 
group of women with IMB. EC was diagnosed significantly 
more frequently in the group of postmenopausal women 
compared to premenopausal ones (2.3% vs. 0.5%; p = 0.04, 
Cramer’s V = 0.08).
There was no significant relationship between histologically 
confirmed EC and the number of pregnancies and deliveries, 
surgery time, hemoglobin level, infertility, abdominal pain, 
hypertension, diabetes, smoking, BMI or breast cancer.
Survival rate of patients  
with unexpected malignancy
We did not observe worsening of prognosis in any patient 
with unexpected EC or ESS. All patients were still alive after 
2–5 years of follow-up.
DISCUSSION
The study found that unexpected malignancy occurred in 
1:84 and, including the precancerous condition (AH), in 
1:67 hysteroscopies performed in women with presumed 
benign lesions, i.e. endometrial polyps and submucosal 
myomas. An unexpected malignant tumor was present in 
1:77 and 1:103 symptomatic (AUB, PMB, pelvic pain, infer-
tility) and asymptomatic women, respectively. Similarly, 
considering the presence of AUB/PMB, occult malignancy 
was diagnosed in 1:76 and 1:100 women with and with-
out AUB/PMB, respectively. In the examined population of 
1,006 women with a preoperative suspicion of a polyp or 
a myoma, the total of 15 patients (1.5%) were diagnosed 
with a malignancy or precancerous condition. Malignancy 
was present in 11/886 (1.2%) and in 2/155 (1.3%) women 
with an ultrasonographic diagnosis of a polyp and submu-
cosal myoma, respectively. In the course of the study, it was 
confirmed that all patients were still alive until December 
2018. Hence, the application of operative hysteroscopy with 
Histology N %
Endometrial stromal sarcoma 2 0.2
Endometrial cancer 10 1.0
Atypical hyperplasia 3 0.3
Polypoid endometrium 269 26.7
Endometrial polyp 409 40.7
Submucous myoma 131 13.0
Polyp + submucous myoma 12 1.2
Normal endometrium + other benign conditions* 167 16.6
No histological result 3 0.3
N = 1,006 women.
*  Endometrial hyperplasia without atypia, adenomyoma, adenomyomatous 
polyp, adenomyosis, cellular leiomyoma, disordered proliferative endome-
trium, fibroadenoma.
Tab. 4. Pathological findings
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the intention of treating benign lesions allowed to recognize 
malignant tumors without worsening the prognosis during 
a short-term observation (2–5 years).
It should be highlighted that our results on the incidence 
of occult malignancy are calculated in relation to an ini-
tial ultrasound diagnosis of intracavitary lesions: polyps, 
myomas or an inconclusive diagnosis of a polyp or myoma. 
This manner of calculating the risk seemed the most appro-
priate, taking into account routine clinical practice, in which 
one must answer the question about the risk of malignant 
tumor in the presence of given ultrasound features.
The question about the potential risk formulated in this way 
seems to be more appropriate for clinicians than the ques-
tion about the chance of malignant tumor when performing 
diagnostic hysteroscopy or panoramic view hysteroscopy 
due to the fact that nowadays the management is based on 
initial diagnosis and symptoms.
Moreover, the necessity of invasive diagnosis and treatment 
of submucosal myomas and polyps is a subject of debate. 
According to our study results, there were no significant 
differences in the incidence of an unexpected malignancy 
in symptomatic and asymptomatic women with presumed 
benign intracavitary lesions. It seems that more accurate 
diagnosis, like sonohysterography, may be an alternative to 
hysteroscopy in such cases. Our results implicate also that 
overall diagnostic accuracy of unenhanced ultrasound per-
formed by different examiners with various levels of exper-
tise is limited. Only in a part of women with a preoperative 
diagnosis of a polyp or myoma was the initial suspicion his-
tologically confirmed, especially with regard to a polyp.
The weak points of our study are: (i) a retrospective design, 
(ii) a single center database, and (iii) lower than expected 
accuracy of primary diagnosis. However, the results reflect 
everyday clinical practice, and therefore probably better 
represent the real diagnostic accuracy of ultrasonography 
in various hands, with a probably higher number of those 
with basic expertise.
The strengths of the study are: (i) the database of prospec-
tively included all consecutive patients with an initial diag-
nosis of an endometrial polyp and submucosal myoma who 
underwent operative hysteroscopy with the intention of 
benign lesion treatment, (ii) inclusion of a relatively large 
group of asymptomatic patients who commonly remain 
under medical observation without surgical intervention 
in other centers, and (iii) the lack of a specific definition of 
a polyp(11), resulting in the heterogeneity of initial diagno-
ses depending on the observer experience, and also regard-
ing diagnoses made by physicians responsible for the selec-
tion for the targeted treatment.
As already mentioned, the real impact of neoplastic cell 
leakage into the peritoneal cavity on overall survival is 
not known due to the lack of randomized prospective 
studies(12–14). Of the ten EC women in our study, only one 
is known to have had a positive peritoneal cytology, and it 
was a patient with concurrent ovarian cancer. Even cytology 
from the patient with type II EC was negative(14).
When it comes to myomas, the incidence varies from 70% 
to 80%, depending on the human race(15). Hysteroscopy is 
the preferred method of treatment for fibroids, whenever 
feasible(16). Data on the incidence of malignant tumors dur-
ing hysteroscopic resection of submucosal myomas are not 
as numerous as in the case of endometrial polyps; also the 
risk factors are less explored. The above issues as well as 
doubts regarding prognosis are discussed in the literature 
mainly in case reports, which indirectly indicates their rare 
occurrence. In the population studied, 2 patients were diag-
nosed with ESS, and the reason for the surgery was HMB. 
A polyp was suspected as the underlying cause of HMB in 
one patient and a myoma in the other. Hence, it is possi-
ble to calculate the ESS risk in the population of women 
with HMB, which in our study amounted was 0.55% 
(2/364). Considering all women with AUB, this risk was 
0.33% (2/608). The literature data show that the risk of ESS 
is 1/800 in women undergoing endometrial ablation due 
to AUB(17).
As already mentioned, hysteroscopic excision of localized 
lesions, apart from specific cases, is not sufficient for the 
treatment of malignant tumors. However, in one of our two 
patients with ESS diagnosed in the specimen from hystero-
scopic resection, no malignancy was found in the material 
from the main surgery, which means that the tumor had 
been removed completely during the previous procedure. 
What is even more interesting, the discussed patient under-
went hysteroscopy twice: after the first surgery, smooth 
muscle tumor of uncertain malignant potential (STUMP) 
was diagnosed, which was the reason for the next proce-
dure, after which ESS was diagnosed. On the other hand, 
there are attempts to treat this type of cancer preserving fer-
tility(18,19) with different results. However, both patients were 
subjected to further hysterectomy with bilateral salpingec-
tomy via laparotomy, and there was no trace of dissemina-
tion in the peritoneal cavity in any of them. Similarly, the 
results of other studies do not indicate a worse prognosis in 
the case of tumors other than EC when recognized in a tis-
sue specimen from hysteroscopy(20).
The main implication of the current study is that the inci-
dence of unexpected malignancy in patients subjected to 
hysteroscopy with the intention to treat benign intracav-
itary lesions, i.e. endometrial polyps and myomas is rela-
tively high. For instance, the risk of occult malignancy in 
women subjected to laparoscopic supracervical hyster-
ectomy is lower than the risk of occult malignancy in all 
presumed myomas: intramural, subserosal, submucosal 
and hybrid according to the PALM-COEIN(21–23). In our 
cohort, there was no significant difference in the incidence 
of malignancy between symptomatic and asymptomatic 
women. Taking into consideration all women with benign 
intracavitary lesions as a target group and ignoring the 
type of lesion and the presence or absence of symptoms, it 
might be reasonable to implement hysteroscopic surgery in 
all women with a suspicion of the above-mentioned benign 
conditions due to relatively high prevalence of malignancy. 
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A high survival rate after operative hysteroscopy in cases 
of an unexpected uterine malignancy may indicate that its 
benefits in the treatment of presumed benign lesions are 
greater than potential concerns, i.e. spreading neoplastic 
cells or worse prognosis(7,24–26). An indirect implication of 
this study is that the implementation of procedures with 
high-power morcellation, such as laparoscopic supracervi-
cal hysterectomy, in cases of presumed benign intrauter-
ine lesions, like endometrial polyps and myomas, should 
be avoided due to a very high risk of occult malignancy 
(greater than 1:100). Further large prospective studies and 
randomized controlled trials should be performed in this 
field to guide the management of polyps and submucosal 
myomas in diverse groups of patients, considering the risks 
and benefits for specific groups of patients (i.e. asymptom-
atic women), and safety of expectant and surgical manage-
ment (hysteroscopic resection).
CONCLUSIONS
The incidence of unlooked-for malignancy in benign intra-
cavitary lesions, i.e. endometrial polyps and submuco-
sal myomas, in women diagnosed by clinicians of various 
expertise in ultrasound is relatively high and greater than 
1:100, which may justify performing hysteroscopic proce-
dures in symptomatic and asymptomatic women, especially 
after menopause. Laparoscopic procedures with power 
morcellation not preceded by previous endometrial sam-
pling should not be considered as an alternative to hystero-
scopic procedures, due to a high risk of occult malignancy 
in presumed benign intracavitary lesions.
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